Nanotechnology resurfaces regularly in the popular and scientific press. But despite the pretty pictures of ‘nano submarines’ patrolling the body for tumour cells in popular magazines and miniature cogs on the cover of Nature , there are few applications of nanotechnology that have actually made it to the market place. So far, dirt‐repelling surface coatings and paint additives are the only commercial applications to result from nano research. Miniature machines and submarines may be some way off, but in the biomedical sector a fledgling industry is emerging that exploits nanotechniques for diagnosis and drug delivery. > It was the physicist and Nobel laureate Richard Feynman who saw the day when it would be possible to build miniature devices bottom‐up, starting with single atoms or molecules It was the physicist and Nobel laureate Richard Feynman who saw the day when it would be possible to build miniature devices bottom‐up, starting with single atoms or molecules. This differs from conventional miniaturisation techniques, which are top‐down. They start with larger substrates, and make it smaller by taking matter away—the miniature cogs in Nature are such an example. Nanoscience today is often defined as the study of systems of the order of 1 to 100 nm in size, although larger structures, for example those made by etching silicon, have been referred to as ‘nano’ as well. On one thing all agree: nanotechnology and its applications are proving a middle ground for the meeting of intellects from a wide diversity of scientific backgrounds; the life sciences, physics, chemistry, engineering, electronics and chemistry to name some. As Hermann Gaub, Chair of Applied Physics at the Ludwig Maximilian University in Munich, remarked, ‘at the nanometer scale, the differences between disciplines disappear.’ Gaub's group studies the biophysics of single molecules, in particular the folding processes of protein molecules. By …